Also categorized in PubMed:
Childhood cancer survival in France, 2000-2008.
x hide permanently

Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.

ncbi.nlm.nih.gov

Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.

J Natl Cancer Inst. 2017 Nov 01;109(11):

Authors: Takagi M, Yoshida M, Nemoto Y, Tamaichi H, Tsuchida R, Seki M, Uryu K, Nishii R, Miyamoto S, Saito M, Hanada R, Kaneko H, Miyano S, Kataoka K, Yoshida K, Ohira M, Hayashi Y, Nakagawara A, Ogawa S, Mizutani S, Takita J